LUPIN Ltd: The Mumbai (Maharashtra)-headquartered trans-national pharma major has said that it’s subsidiary - Nanomi B.V. has completed the divestiture of the entire stake (99.82%) in it’s Japanese generics subsidiary/arm - Kyowa Pharmaceuticals Industry Co, to Unison Capital Partners IV, LPS and Unison Capital Partners IV (F). L.P. - a private-equity (PE) fund in Japan. The transaction generates post-tax net cash inflow of approximately JPY 33,429 mln (Rs 2,157.60 Cr) - post which the co’s net debt reduces alarmingly to Rs 1,075.30 Cr from Rs 4,361.80 Cr previously, & net debt-to-equity (D/E) ratio stands at 0.08 times Vs 0.32 times previously.
Feedback
LUPIN 
Reputation: 13,324 • Dec 17, 2019 6:26 PM
Vote
Comment
Share